CORCEPT Therapeutics: President Roberto Vieira Wandenkolk sold 8,333 shares

What happened

• Roberto Vieira Wandenkolk, president, oncology, exercised options for 8,333 shares at $21.63 on Oct 2, 2026, for $180,243 and sold 8,333 shares in open-market transactions on Oct 2, 2026, for aggregate proceeds of $967,448. The filing also reports a derivative disposition of 8,333 shares at $0.00.

Key details

• Transaction dates and prices: Oct 2, 2026 — exercised 8,333 shares @ $21.63 (cost $180,243); sold 1,100 shares @ $114.52 ($125,973), 2,086 shares @ $115.73 ($241,412), and 5,147 shares @ $116.58 ($600,063). Sales aggregate $967,448. The filing notes sale price ranges of $114.03–$114.90, $115.16–$116.04 and $116.24–$117.22 for the respective sale blocks.
• Shares owned after the transaction: not stated in the provided filing excerpt.
• Footnotes: F1 lists 1,347 unvested restricted stock shares with vesting on one-year anniversaries; F2 indicates a 10b5-1 plan was used for at least one sale; F3–F5 explain weighted average sale prices and price ranges; F6 describes the option vesting schedule (25% vested Jan 29, 2025, remainder monthly through Jan 29, 2028).
• Filing date: Form 4 filed Oct 5, 2026.

Why it may matter

• The filing shows an option exercise and contemporaneous open-market sales; the form reports a derivative disposition at $0.00 alongside the sales.
  A filing does not show why the insider traded or why the company acted.